chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash over while body; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of RASH and DIZZINESS in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH and DIZZINESS. At the time of the report, RASH  and DIZZINESS outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and Treatment medications were not provided by reporter.
None - Hep A #2 given 7/12/12. On 9/19/12 client mom consulted NP who returned to HD. Denies any prior concerns other than "dent in leg". No other symptoms.
Received vaccination on Jan. 20th 2021. No symptoms till two days later on Jan 22nd 2021. Symptoms include achy muscles, redness, and quarter sized hives all over body. Main location of hives were located on L and R shoulders and back.  Symptoms continued for three days then stopped completely.  Redness and hives symptoms then reappeared on Feb 4th 2021. Continuing off and on till Feb 9th 2021.
Patient reports "vertically misaligned" vision; unable to touch nose with finger with or without eyes open; other stroke-like symptoms; incontinence; extreme lethargy; very impaired mobility.
7 hours after shot I had severe vomiting and diarrhea and chills; 7 hours after shot I had severe vomiting and diarrhea and chills; 7 hours after shot I had severe vomiting and diarrhea and chills; This is a spontaneous report from a contactable nurse (patient). A 67-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly into the left arm on 11Jan2021 02:45 at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscularly into the left arm on 21Dec2020 03:00 at a single dose for covid-19 immunization at the age of 67-year-old as well. On 11Jan2021 09:45, 7 hours after the shot she had severe vomiting, diarrhea and chills. The patient received no treatment for the events reported and was not pregnant at the time of administration of the vaccine. Outcome of the events recovered on an unspecified date in Jan2021.  Information on lot number/batch number was requested.
she got sick; dizziness; lost of appetite; This is a spontaneous report from a contactable consumer or other non health professional. This is a reported received from a Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number and expiry date was not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient also received first dose of bnt162b2 (Solution for injection) via an unspecified route of administration on an unspecified date as 1st dose, single for Covid-19 immunisation. The patient got sick she said she is experiencing dizziness, lost of appetite she wanted to know what she should do. The outcome of all the events was unknown.  Information on the lot/batch number has been requested.  Follow-up (07MAY2021): Follow-up attempts completed. No further information expected.
Hives on right arm at the area of the elbow.  On the outer side of the elbow, not on the cease or heel of the elbow.  Covering an area 3 by 4 inches. Mild itching sensation.
Fever, beginning on day after shot, lasted 2 days. The second day after shot he fainted upon standing up and hit the wall, nausea, fever, fatigue, chills.
Chicken pox reported after mother noticed macular rash on left side that spread to chest, back & down legs on face and in hair. Beginning to dry with scabbing on 3/15/04. Mom used Calamine lotion for itching. Recovery uneventful.
Heart palpitations; Shortness of breath; tremor; stiff neck; gait dysfunction; slurred speech; Migraine; Visual impairment and changes; Itching over whole body; slurred speech progressing to inability to speak; Neurological effects; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 1 at vaccination age of 61-year-old via an unspecified route of administration, administered in the left arm on 31Mar2021 11:30 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history included lyme (lyme disease), multiple chemical sensitivity, fibromyalgia and known allergies. The patient did not have covid prior vaccination. Concomitant medication included unspecified medications. On 31Mar2021 11:30, the patient experienced heart palpitations, shortness of breath, neurological effects, tremor, stiff neck, gait dysfunction, slurred speech progressing to inability to speak. migraine, visual impairment and changes and itching over whole body. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for the adverse event included osteopathic manipulation. The patient has not been covid tested post vaccination. The outcome of the events was recovering.  Information about lot/batch number has been requested.
2 swollen lymph nodes in her neck; chills; stayed in bed all day; like the flu; This spontaneous case was reported by a consumer and describes the occurrence of BED REST (stayed in bed all day), INFLUENZA (like the flu), LYMPHADENOPATHY (2 swollen lymph nodes in her neck) and CHILLS (chills) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 026L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced BED REST (stayed in bed all day), INFLUENZA (like the flu) and CHILLS (chills). On 18-Feb-2021, the patient experienced LYMPHADENOPATHY (2 swollen lymph nodes in her neck). At the time of the report, BED REST (stayed in bed all day), INFLUENZA (like the flu), LYMPHADENOPATHY (2 swollen lymph nodes in her neck) and CHILLS (chills) outcome was unknown.            Treatment details included Tylenol(paracetamol) and motrin (Ibuprofen).
Itching developed at site of injection within 5 minutes. Developed 6 cm erythematous area at site and a 2 mm raised erythematous welt at injection site.  A second 2 cm erythematous area was noted superior to primary urticarial site.
Swelling, erythema and warmth at injection site. Talked with parent over the phone
STROKE LIKE SYMPTOMS; VISION ABNORMAL; This spontaneous report received from a consumer via social media concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported, 1 total administered 11-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported.  On 12-APR-2021, Monday afternoon, the patient felt symptoms similar to an stroke and at the end of the evening he felt normal. It was reported that only his vision was out of place. The physicians could not explain what was wrong as everything looked normal in test and scan (unspecified). According to them it was a side effect of vaccine. Laboratory data included: Eye exam (NR: not provided) Normal, and Investigation (NR: not provided) Normal.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stroke like symptoms on 12-APR-2021, and had not recovered from vision abnormal. This report was serious (Other Medically Important Condition).; Sender's Comments: 20210431142-Covid-19 vaccine ad26.cov2.s-stroke like symptoms  . This events is considered unassessable. The events has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the events.
Low fever; red from knee to hip on right leg; knot at one of two injection sites on right leg; sleepy; started falling backwards when seated; stopped trying to crawl; staring;at the time we didn't realize he was starting with small seizures until it was obvious on 6/10/2015.
Patient did not have any adverse events for first vaccine. Second vaccine resulted in fatigue, muscle pain, sweating and excrutiating eye pain. She did not have chills or check for fever. These lasted for 2 days on 4/28&29 however the eye pain continued to 4/30 and is unresolved at the time of reporting. When asked the patient described the eye pain in both eyes as more of a pressure than a stabbing or throbbing.
Tiredness; Joint pain; A spontaneous report was received from a consumer concerning a 81-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fatigue and arthralgia.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the patient experienced the events tiredness and joint pain.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report,the outcome of events, tiredness, joint pain was unknown.
Suspected vaccination failure; Outbreak; Tingling that always comes before an outbreak; Extremely sick; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, tingling and sickness. The patient was treated with acyclovir. On an unknown date, the outcome of the vaccination failure, shingles, tingling and sickness were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, tingling and sickness to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's wife. The age at vaccination was not reported. The patient received Shingles vaccine and was extremely sick for at least 2 weeks after the vaccination. The patient took acyclovir when tingling occurs before shingles outbreak. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. This case is linked with the case US2021AMR230893, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR230893:Same reporter.
On June 15, 2021 I had ringing in my ears and a full feeling ears. No pain associated with it but loud noises are bothering me now. I went to the urgent care on June 24, 2021, doctor checked both ears but my left ear was infected and he wasn't sure if the right ear had an infection or not. I also had a sinus infection but I did not have any symptoms with the sinus infections. He prescribed me azithromycin 250mg dose pack, I had to take it for 5 days and suppose to stay in your system for 10 days. The medicine did not help and I still have the same symptoms. I think I am going to see an ENT (ear, nose and throat) doctor.
This spontaneous report was received from a certified medical assistant regarding a 17 month old male patient. On 06-JUN-2014 the patient was vaccinated with M-M-R II. Past medical history included eczema after vaccine. Concomitant medications were not reported. The patient was scheduled to receive his M-M-R II vaccine on 04-JUN-2014 in the allergist's office. The healthcare worker stated that they reconstituted the M-M-R II vaccine in the primary care office, then transported it to the allergist's office, that it was then stored in the refrigerator and administered to the patient two days later. No adverse effects were reported. The outcome of did not receive vaccine on scheduled date is unknown. No adverse effects were reported. Additional information has been requested.
Evening of date of service Left upper arm became red, swollen and tender to touch. Ice pack applied. Still same next day. Patient states same events occurred after 1st dose 1/15/2004.
I had COVID-19 and I had sinus pressure, head cold symptoms, sore throat, loss of taste and smell.
weak; nausea; doesn't feel like eating; watery type of diarrhea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 67 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 18Mar2021 (Lot number: EN6298) at the age of 67 years as dose 2,single for covid-19 immunisation. Relevant medical history included: "Diabetes" (ongoing); "Hypertension" (ongoing); "Overweight" (unspecified if ongoing); "fell" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Batch/lot number: EN6198   , Dosage text: right arm dose 1), administration date: 25Feb2021, for COVID-19 immunization. The following information was reported: DIARRHOEA (non-serious) with onset 12Apr2021, outcome "unknown", described as "watery type of diarrhea"; ASTHENIA (non-serious), outcome "not recovered", described as "weak"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; EATING DISORDER (non-serious), outcome "not recovered", described as "doesn't feel like eating".  Additional information: This report is in reference to the caller's husband. While reporting her own experience with the Covid 19 vaccine she reports her husband received his second Covid 19 vaccine on 18Mar2021. She reports her husband is having the watery type of diarrhea. Her husband is also weak. She reports he is diabetic. She also reports he has nausea. Email: Caller declines HCP: Not provided .For her husband's report, she states they share the same address and to leave her phone number on his report because he never checks his phone. When probing for which arm her husband received his Covid 19 vaccines in, she reports the right arm because he's left handed and he fell down a while back. When probing for information on the fall she reports he slipped and fell. She reports that was way before he got the Covid 19 vaccine. Maybe 2-3 months prior to the vaccine. While probing for her husband's height and weight, the caller puts her husband on the phone and he continues with the report. He confirms he is having diarrhea and weakness. He thinks the weakness is because he doesn't feel like eating. He reports the diarrhea may have gotten a bit better but it's still pretty bad. Second Covid 19 vaccine received on 18Mar2021, Lot# EN6298, right arm. First Covid 19 vaccine information is in the suspect product field. When probing medical history and concomitant medications he reports he has diabetes, hypertension and he's overweight. He reports he takes medication for his hypertension and diabetes and they are both well controlled. He doesn't feel they are relevant. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) First Covid 19 vaccine. Additional Administered Vaccines If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect: no  No follow-up attempts are possible. No further information is expected.
patient began to experience red rash and itching from below the vaccine site down to elbow area. worst symptoms last night (10/29/22) and feeling much better with rash resolution today
Information has been received from a pharmacist concerning a 72 year old female patient who on 25-APR-2012, was vaccinated with ZOSTAVAX (Merck) (dose, route and site of administration not reported, Lot # 670986/0730AA, exp August 2013). The pharmacist reported that on 01-MAY-2012, the patient developed shingles. No laboratory diagnostic studies were performed. The patient sought medical attention by calling the pharmacist. At the time of report the patient has not recovered. Follow-up information has been received from the pharmacist who stated that the patient with no illness at time of vaccination was subcutaneously vaccinated into left arm with the first dose of ZOSTAVAX (Merck) at 15:00. On 01-MAY-2012, the patient developed painful rash and the physician diagnosed as shingles on her upper quadrant. It was reported that relevant diagnostics tests and laboratory data were not available. At the time of reporting, the patient's outcome was unknown. Shingles was considered to be disabling by the pharmacist. Additional information has been requested.
four patients who present with symptoms of hyperthyroidism after receiving SARS-CoV-2 mRNA vaccine; This is a literature report.  An adult female patient received BNT162b2 (COVID-19 VACCINE NOS MANUFACTURER UNKNOWN), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Graves disease" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HYPERTHYROIDISM (medically significant), outcome "unknown", described as "four patients who present with symptoms of hyperthyroidism after receiving SARS-CoV-2 mRNA vaccine". The patient underwent the following laboratory tests and procedures: Blood thyroid stimulating hormone: positive, notes: range 6.21-11.87 IU/L.; Sender's Comments: Based on the information provided, and a temporal association, a causal association between reported event hyperthyroidism and suspect BNT162B2 cannot be excluded.This impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202300081270 Same article/drug/event and different patient;
Pt passed out about 2 minutes after receiving flu shot she came out of it within a minute and stayed in our office for observation about 15 min.
I received the Janssen (J&J) vaccine at 11:12pm on 3/5/2021. I went to bed with a slightly sore arm. I woke up the following day 3/6/2021 with a slight headache and feeling a little achy. At around 11:00-12:00pm on 3/6/2021 I started having a fever, chills, aches, an increasingly bad headache. For the next 18 hours I had a fever, shaking, aches, bad migraine headache, diarrhea, nausea, and vomiting. I felt increasingly sick and my lowest point was at around 9:00pm on 3/6/2021 when I vomited. Around 5:00-6:00am on 3/7/2021 I felt considerably better and no longer had a fever. I was exhausted and still had a headache. I was very fatigued for the next two weeks.   I was menstruating when I received the vaccine. My menstruation stopped when I was having side effects for about 2-3 days and then started again.  In addition, I have psoriasis and on 3/7/2021 my skin looked noticeably better than it had looked before I received the vaccine. The psoriasis I had on my hands almost completely disappeared. A few days later, my psoriasis looked worse than I had looked before I received the vaccine. Today 3/29/2021, my psoriasis is back to how it looked right before I received the vaccination.
Arm soreness starting the next day after injection and lasting for 4 days Fatigue starting about 6 hours after injection and lasting for 2 days Brain fog starting about 6 hours after injection and lasting for 2 days Mild headache starting about 6 hours after injection and lasting for about 4 days
Intussusception 4 mo after completing 3 doses ROTATEQ. 9/23/09 Medical records received for date of service 7/22/09 to 7/23/09. DX Intussusception with successful reduction by air contrast enema. Sudden onset of abdominal pain and increased irritability.  Nausea & vomiting, bloody BM, minimal intake PO, negative for fever/chills.  Abdomen tender to palpate, firm palpable mass RUQ.   8/20/09 Vaccine records received. Pneumo / Wyeth Prevnar Lot# D33126 IM 2 Previous doses. Administered on 3/27/09 per vaccine records. \ksk  10/1/09 ICD-9 Codes received: 560.0 Intussusception.
Itchy right eye only, conjested right nostril, tiny bumps around the lips, swelling the lips, dizzyness/confusion, swelling of the eyelid, bumps on eyelid
This spontaneous report as received from a medical assistant refers to unknown number of patients of unknown ages and genders. On an unknown date unknown number of patients were vaccinated with a dose of improperly stored GARDASIL (lot number, expiration date, dose, frequency, route were not reported). No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient developed bulging fontanelle five days after vaccine (8/10/20).  She also had developed a fever on day of vaccination and a rash soon after the fever.  Fever and rash were gone by the time she was seen in clinic.  The bulging fontanelle was still present per parents the following day (8/11/20) when provider called family.  She was otherwise acting normal without any other signs of increased intracranial pressure.
Seen on 5/21/2000, pale erythema and minimal induration, extending distally from injection 4cm X 7cm. Seen in office on 5/22/2000, pale erythema, no induration, pale center extending 10cm X 10cm. Also, palate red and had complained of pain within throat.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 16-OCT-2015 03:51, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L016427, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high temperature and low temperature were 6.5 and 1.2 (3 hours 6mins) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.